Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?

on MSN ago, source:

Vincerx Pharma Inc (NASDAQ:VINC) presented preliminary Phase 1 data for VIP236 and updates on pipeline progress at the ...

Vincerx Pharma, Inc. (VINC)

3d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Vincerx Pharma Inc (VINC) Gets a Buy from Leerink Partners

8d ago, source:

Leerink Partners analyst Jonathan Chang reiterated a Buy rating on Vincerx Pharma Inc (VINC – Research Report) on April 8. The ...

Vincerx in selloff after early-stage data for cancer therapy

on MSN ago, source:

Vincerx Pharma (VINC) stock drops 65% after disappointing initial data from Phase 1 trial for lead asset VIP236 in solid ...

Vincerx Pharma Inc Ordinary Shares

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

20d ago, source: Business Insider

March 29, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting ...

Vincerx Pharma Inc (VINC) Reports Q4 and Full Year 2023 Financials: A Close Look

21d ago, source: Yahoo Finance

Warning! GuruFocus has detected 2 Warning Signs with VINC. On March 29, 2024, Vincerx Pharma Inc (NASDAQ:VINC), a clinical-stage biopharmaceutical company specializing in novel cancer therapies ...

Vincerx Pharma Inc

1mon ago, source: CNN

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new ...

Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

21d ago, source: Stockhouse

March 29, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting ...

Vincerx Pharma Inc Ordinary Shares VINC

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...